Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. freshman Avg
|
New words:
abdominal, acid, acknowledge, add, adrenergic, adriamycin, aforementioned, alpha, answer, atenolol, Bach, BNC, Boston, breadth, built, Bulletin, Buspar, capecitabine, category, cavity, chemistry, CMC, colorectal, constrained, counterclaimed, covenant, dealing, depth, derecognition, devoid, discharge, dismissed, doxorubicin, EITF, ejaculation, endeavor, endothelin, Eprova, Etoposide, evade, exert, fainting, fifty, FIN, floating, follicle, Gliobastoma, glioblastoma, Global, greatest, guidance, healing, hearing, implied, impotence, incidence, incontinence, Indemnity, intermittent, isomer, Kayaku, Lehman, leucovorin, levofolinate, levofolinic, levoleucovorin, LFA, libido, literature, lt, Mechanistically, menopause, menstruating, Merck, merit, methotrexate, mg, mid, moderate, modification, motor, movement, multiforme, multiplied, myoma, nearer, Nefazodone, negative, Nippon, noninvasive, nonvested, onset, organizational, osteogenic, osteosarcoma, panel, peptide, perpetual, pharmacology, platform, poised, premium, pronouncement, properly, prospective, PSA, PTE, pure, quantification, ratio, receptor, recipient, reductase, refusal, regimen, reinvested, reinvestment, relaxing, relief, remote, RenaZorb, Renshaw, reproductive, rescue, residual, rich, Rodman, SAB, Sanofi, sarcoma, SCO, Score, sensory, serve, simultaneously, SPA, sparing, spirit, Stadol, Subscription, suggest, Supplementary, synergism, synergy, Targent, temperature, tentative, thefourth, thesecond, tightly, Today, touch, toxicology, transition, undergone, undervalued, underway, unique, unpromising, unrecognized, urethra, urology, USPTO, uterine, vibration, Wellcome, whichever, willfully, wound, Wyeth
Removed:
accompanied, adjusted, aggressively, Akorn, asserted, attaching, awarding, bear, borne, citizen, combined, compendia, computed, consistent, controlled, coordinated, crucial, decided, devoted, diseased, distributor, eighteen, eoquintm, feature, forma, formed, harming, herbal, impacting, Impax, incidental, investigation, jointly, Lannett, larger, leased, listing, localized, lymph, monoclonal, month, move, mutually, negotiating, offsetting, ophthalmic, opposition, otic, petition, Pharmacopoeia, Philadelphia, Pliva, pro, professional, prohibited, prolongation, radiotherapy, ratably, reclassified, recording, redemption, reorganization, reverse, room, rose, routine, satisfactory, shift, Sicor, sought, split, structural, supplier, survival, thereunder, utilizing, wholly
Filing tables
Filing exhibits
- 10-K Annual report
- 10.38 Agreement by and Between Registrant and Glaxo Group Limited
- 10.39 First Amendment to the Development and Marketing Agreement Dated 11/10/2006
- 10.40 Supply and Distribution Agreement Dated 11/10/2006
- 21 Subsidiaries of the Registrant
- 23.1 Consent of Kelly & Company
- 31.1 Section 302 Certification of the Chief Executive Officer
- 31.2 Section 302 Certification of Vice President of Finance
- 32.1 Section 906 Certification of the Chief Executive Officer
- 32.2 Section 906 Certification of Vice President of Finance
Related press release
SPPI similar filings
Filing view
External links